Solid Biosciences's total assets for Q1 2026 were $422.89M, an increase of 81.86% from the previous quarter. SLDB total liabilities were $48.76M for the fiscal quarter, a -7.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.